To prevent thrombosis without increasing hemorrhage by using a modified annexin protein, preferably annexin V.
The present invention provides a method for screening a modified annexin protein that modulates thrombosis. The method includes: (a) contacting a thrombosis test system with at least one test modified annexin protein under conditions permissive for thrombosis; (b) evaluating antithrombotic activity in the presence of the test modified annexin protein; and (c) comparing the antithrombotic activity in the presence of the test modified annexin protein with the antithrombotic activity in the absence of the test modified annexin protein, wherein a change in the antithrombotic activity in the presence of the test modified annexin protein is indicative of a modified annexin protein that modulates thrombotic activity.
JP2000504210A | 2000-04-11 | |||
JPH05508664A | 1993-12-02 | |||
JP2001500116A | 2001-01-09 |
WO1998031383A1 | 1998-07-23 | |||
US5612460A | 1997-03-18 |
THROMBOSIS RESEARCH, vol. 69, JPN6011009049, 1993, pages 289 - 296, ISSN: 0001852080
Tadashi Masui
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Next Patent: BIOLOGICALLY ACTIVE PEPTIDE